149 related articles for article (PubMed ID: 1735694)
21. The effect of hypoxic radiosensitizer after mild hyperthermia in C3H mammary carcinoma.
Ohizumi Y; Murayama C; Maezawa H; Mori T
Tokai J Exp Clin Med; 1984 Oct; 9(4):331-7. PubMed ID: 6537042
[TBL] [Abstract][Full Text] [Related]
22. Response of murine tumours to combinations of CCNU with misonidazole and other radiation sensitizers.
Siemann DW
Br J Cancer; 1982 Feb; 45(2):272-81. PubMed ID: 6460517
[TBL] [Abstract][Full Text] [Related]
23. In vitro assessment of the oncogenic potential of nitroimidazole radiosensitizers.
Hei TK; Geard CR; Osmak RS; Hall EJ
Int J Radiat Oncol Biol Phys; 1985 Sep; 11(9):1653-8. PubMed ID: 3839777
[TBL] [Abstract][Full Text] [Related]
24. Enhanced tumor responses through therapies combining CCNU, MISO and radiation.
Siemann DW; Hill SA
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1623-6. PubMed ID: 6480451
[TBL] [Abstract][Full Text] [Related]
25. Studies in radiosensitizing effects of misonidazole and SR-2508 on C3H/He mouse mammary tumors.
Ono K; Takahashi M; Nishidai T; Dodo Y; Shibamoto Y; Hiraoka M; Yukawa Y; Abe M
Radiat Med; 1984; 2(1):71-5. PubMed ID: 6242712
[TBL] [Abstract][Full Text] [Related]
26. Manipulation of radiobiological hypoxia in a human melanoma xenograft to exploit the bioreductive cytotoxicity of RSU-1069.
Cole S; Stratford IJ; Adams GE
Int J Radiat Biol; 1989 Nov; 56(5):587-91. PubMed ID: 2573651
[No Abstract] [Full Text] [Related]
27. Bioreductive drugs as post-irradiation sensitizers: comparison of dual function agents with SR 4233 and the mitomycin C analogue EO9.
Adams GE; Stratford IJ; Edwards HS; Bremner JC; Cole S
Int J Radiat Oncol Biol Phys; 1992; 22(4):717-20. PubMed ID: 1544844
[TBL] [Abstract][Full Text] [Related]
28. Depletion of glutathione in vivo as a method of improving the therapeutic ratio of misonidazole and SR 2508.
Yu NY; Brown JM
Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1265-9. PubMed ID: 6236185
[TBL] [Abstract][Full Text] [Related]
29. A fluorinated 2-nitroimidazole, KU-2285, as a new hypoxic cell radiosensitizer.
Sasai K; Nishimoto S; Shimokawa K; Hisanaga Y; Kitakabu Y; Shibamoto Y; Zhou L; Wang J; Takahashi M; Kagiya T
Int J Radiat Oncol Biol Phys; 1991 Jun; 20(6):1249-54. PubMed ID: 1828462
[TBL] [Abstract][Full Text] [Related]
30. Sensitization by SR-2508 plus Ro 03-8799.
Stone HB; Luu YH; Lam KN
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1097-100. PubMed ID: 2943707
[TBL] [Abstract][Full Text] [Related]
31. RSU 1069, a 2-nitroimidazole containing an alkylating group: high efficiency as a radio- and chemosensitizer in vitro and in vivo.
Adams GE; Ahmed I; Sheldon PW; Stratford IJ
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1653-6. PubMed ID: 6548211
[TBL] [Abstract][Full Text] [Related]
32. Influence of misonidazole, SR-2508, RSU-1069 and WR-2721 on spontaneous metastases in C57BL mice.
Kanclerz A; Chapman JD
Int J Radiat Oncol Biol Phys; 1988 Feb; 14(2):309-16. PubMed ID: 2828290
[TBL] [Abstract][Full Text] [Related]
33. Combinations of radiation and misonidazole in a murine lung tumor model.
Siemann DW; Kochanski K
Radiat Res; 1981 May; 86(2):387-97. PubMed ID: 7232698
[No Abstract] [Full Text] [Related]
34. Potentiation of alkylating chemotherapy by dual function nitrofurans in multi-cell spheroids and solid tumors.
Siemann DW; Sutherland RM
Radiother Oncol; 1992 Aug; 24(4):239-45. PubMed ID: 1410579
[TBL] [Abstract][Full Text] [Related]
35. Clinical trials with hypoxic cell sensitizers: time to retrench or time to push forward?
Urtasun RC; Coleman CN; Wasserman TH; Phillips TL
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1691-6. PubMed ID: 6237083
[TBL] [Abstract][Full Text] [Related]
36. Radiosensitization by 2-nitroimidazole nucleoside analog RP-170: radiosensitizing effects under both intravenous and oral administration.
Murayama C; Suzuki A; Sato C; Tanabe Y; Miyata Y; Shoji T; Suzuki T; Sakaguchi M; Mori T
Int J Radiat Oncol Biol Phys; 1992; 22(3):557-60. PubMed ID: 1531214
[TBL] [Abstract][Full Text] [Related]
37. The effect of hydralazine on the tumor cytotoxicity of the hypoxic cell cytotoxin RSU-1069: evidence for therapeutic gain.
Chaplin DJ; Acker B
Int J Radiat Oncol Biol Phys; 1987 Apr; 13(4):579-85. PubMed ID: 3558048
[TBL] [Abstract][Full Text] [Related]
38. Enhancement of artificial lung metastases by misonidazole.
Rockwell S; Nierenburg M; Irvin CG
Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1395-8. PubMed ID: 6469763
[TBL] [Abstract][Full Text] [Related]
39. Radiation sensitization and chemopotentiation: RSU 1069, a compound more efficient than misonidazole in vitro and in vivo.
Adams GE; Ahmed I; Sheldon PW; Stratford IJ
Br J Cancer; 1984 May; 49(5):571-7. PubMed ID: 6547051
[TBL] [Abstract][Full Text] [Related]
40. In vivo potentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea by the radiation sensitizer benznidazole.
Siemann DW; Morrissey S; Wolf K
Cancer Res; 1983 Mar; 43(3):1010-3. PubMed ID: 6825075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
